Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Clinical Colorectal Cancer|August 29, 2018
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal CancerKenji Tsuchihashi, Mamoru Ito, Toshikazu Moriwaki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 13, 2017
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)Yuji Miura, Yasutaka Sukawa, Shuichi Hironaka, et al.
The Oncologist|November 15, 2018
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal CancerYoshihiko Fujita, Masataka Taguri, Kentaro Yamazaki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 4, 2018
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)Ken Kato, Taroh Satoh, Kei Muro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 22, 2018
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched studyAkitaka Makiyama, Kenji Kunieda, Masaaki Noguchi, et al.
Plos One|December 14, 2022
Establishment of preanalytical conditions for microRNA profile analysis of clinical plasma samplesKuno Suzuki, Tatsuya Yamaguchi, Masakazu Kohda, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2020
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)Daisuke Sakai, Hiroya Taniguchi, Naotoshi Sugimoto, et al.
Pageof 19